Pfizer Inc. Stock Rises From the Dead, Deserves to Be in Your Portfolio

Pfizer Inc. (NYSE:PFE) was once the can-do-no-wrong pharmaceutical giant in the market.PFE stock has tripled off its 2008 financial crisis low to $37 per share and has returned about 7% annually since then — plus dividends.The question is whether PFE stock goes stagnant from here or if it is poised to grow.